Eubiologics IPO Part 3 - IPO Bookbuilding Results & Personal View
Eubiologics IPO price was set at ₩6,000, the lowest end of the indicative price band, after conducting the demand survey (bookbuilding) (Jan 9-10)...
463 Views
Eubiologics IPO Part 2 - Growth Potential & Appropriate Valuation Level
* In Part 2 (as below), I examined the company's business fundamentals in more detail along with its growth potential and appropriate valuation...
210 Views
Eubiologics IPO Part 1 - Schedule, Financials & Valuation
Eubiologics is a very "young" vaccine company that develops an oral cholera vaccine product called "Euvichol". This company will be Korea's first...
350 Views
Korea Stock Market Monthly Recap #9 - (December 2016)
The economic hope post Trump win continued to play out in the global equity markets in December. Dow Jones Industrial Average was up 3.3% and...
459 Views
Celltrion Healthcare IPO - Early Review on Key Issues
Celltrion Healthcare, which is Celltrion (068270)’s overseas sales and marketing unit, submitted the application for preliminary screening for...
257 Views